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Available online 26 July 2013Abstract In the present study, we examined the effect of the over-expression of LMNA, or its mutant form progerin (PG),
on the mesoderm differentiation potential of mesenchymal stem cells (MSCs) from human umbilical cord (UC) stroma using a
recently described differentiation model employing spheroid formation.
Accumulation of lamin A (LMNA) was previously associated with the osteoarthritis (OA) chondrocyte phenotype. Mutations of
this protein are linked to laminopathies and specifically to Hutchinson–Gilford Progeria Syndrome (HGPS), an accelerated aging
disease. Some authors have proposed that a deregulation of LMNA affects the differentiation potential of stem cells.
The chondrogenic potential is defective in PG-MSCs, although both PG and LMNA transduced MSCs, have an increase
in hypertrophy markers during chondrogenic differentiation. Furthermore, both PG and LMNA-MSCs showed a decrease in
manganese superoxide dismutase (MnSODM), an increase of mitochondrial MnSODM-dependent reactive oxygen species (ROS)
and alterations in their migration capacity. Finally, defects in chondrogenesis are partially reversed by periodic incubation with
ROS-scavenger agent that mimics MnSODM effect.
Our results indicate that over-expression of LMNA or PG by lentiviral gene delivery leads to defects in chondrogenic
differentiation potential partially due to an imbalance in oxidative stress.
© 2013 Elsevier B.V. All rights reserved.Abbreviations: MSCs, mesenchymal stem cells; LMNA, lamin A; PG, progerin; UC, umbilical cord; HGPS, Hutchinson–Gilford Progeria
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1138 J. Mateos et al.Introduction Material and methodsMSCs are multipotent cells having the capacity to differ-
entiate into various cell lineages, some of which generate
bone, cartilage and adipose tissue (Arufe et al., 2011).
Cells expressing MSC markers have been found in many
tissues including the synovial membrane and cartilage tissues
(Hermida-Gómez et al., 2011). In addition, osteoarthritic
synovial membrane and cartilage contain more cells expressing
MSC markers than do synovial membranes from healthy joints
(Nagase et al., 2008). MSCs are likely to be agents of connective
tissue homeostasis and repair.
Lamin A and lamin C (A-type lamins, both encoded by the
LMNA gene) are major components of the mammalian nuclear
lamina, a complex pertinacious structure that acts as a
scaffold for protein complexes that regulate nuclear structure
and function (Gruenbaum et al., 2003; Prokocimer et al.,
2009). Mutations in the LMNA gene play a key role in the
pathogenesis of a group of diseases called laminopathies,
affecting mesoderm tissues (Worman et al., 2010). One of the
most studied laminopathies is Hutchinson–Gilford Progeria
Syndrome (HGPS) which is due, in most of the cases, to nuclear
accumulation of a permanently farnesylated, mutant form
of prelamin A called progerin (PG) (Eriksson et al., 2003). HGPS
is a very rare and fatal genetic disorder characterized
by cellular senescence and an early onset of pathologies
typical of advanced age such as atherosclerosis, myocardial
infarction, stroke or OA (Hennekam, 2006). Remarkably, PG
is also present in normal cells and appears to progressively
accumulate during aging of non-HGPS cells (Wang et al.,
2008). Besides producing structural defects in the nuclear
lamina, it has also been suggested that PG may interfere
with the proposed gene regulatory function of lamins,
specifically the regulation of the p16/Rb pathway necessary
to maintain balance between differentiation and proliferation
of multipotent mesenchymal stromal or stem cells (MSCs) in
tissue regeneration (Espada et al., 2008; Scaffidi and Misteli,
2008; Hernandez et al., 2010).
Recently, increased accumulation of lamin A in osteoarthri-
tis (OA) chondrocytes and cartilage (Ruiz-Romero et al., 2008;
Attur et al., 2012) has been reported. OA is one of the most
common skeletal disorders clinically manifested by joint pain,
swelling and progressive loss of function. It is characterized
by cartilage degradation, hypertrophy of the subchondral bone
and osteophyte formation at the joint margins (Lamas et al.,
2010). Although the underlying molecular mechanisms involved
in the disease remain unknown, the etiology of OA has been
considered an articular cartilage disorder induced by mechanical
stress, articular injuries, involvement of inflammatory mediators
and aging. Evidence suggests that cellular senescence of the
chondrocyte is inherent to the OA process (Loeser, 2011). Finally,
progression of the disease has been shown to be therapeutically
modulated by MSCs (Mafi et al., 2011; van Buul et al., 2012).
The aim of this study was to demonstrate whether lamin A
deregulation in MSCs modulates the chondrogenesis process.
We demonstrated that over-expression of lamin A and PG
reduces the chondrogenic capacity of MSC. We also provided
evidence that linked those defects to alterations in oxidative
stress response through using N-acetylcysteine which protects
against hypoxia produced by production of oxygen reactive
species (Cillero-Pastor et al., 2008).Tissue collection
Human UCs were obtained from cesarean sections performed
on healthy women at the Maternity Facility of Complejo
Hospitalario Universitario A Coruña (CHUAC). All tissues were
obtained with fully informed consent and ethical approval
by the supervisor of the Ethical Committee (CEIC) of Galicia.
The UC donors were between 26 and 35 years-old.Isolation and culture of MSCs
MSCs were isolated from UC stromal tissue using a previously
described protocol (Arufe, de la Fuente et al., 2011). Briefly,
the tissuewaswashedwith phosphate-buffered saline (PBS) and
cut in small pieces, termed “explants;” which were incubated
for three five-minute periods in an enzymatic cocktail contain-
ing 1.2 U/mL dispase and 112 U/mL collagenase type I (Sigma-
Aldrich, St. Louis, Missouri, USA). The explants were cultured
in Dulbecco's Modified Eagles Medium (DMEM) with 10% fetal
bovine serum (FBS), 1% penicillin and 1% streptomycin (Sigma-
Aldrich) until adhered to the plastic plate. After three days,
the explants were removed, leaving the attached UC MSCs,
which continued monolayer culture in the same medium.
When the cells were 90% confluent, they were removed
from the plate using 2% trypsin (Sigma-Aldrich) in PBS and
induced to differentiate towardmesodermcell lines. The cells
were characterized by flow cytometry using a FACSAria flow
cytometer (BD Bioscience, Madrid, SP) to check the following
surface markers: PE-conjugated anti-human CD73 (1:20 from
BD Pharmingen); PE-Cy5.5-conjugated mouse anti-human
CD90 (1:20 from BD Pharmingen); FITC mouse anti-human
CD105: (1:100 from Serotec, Bavaria, Germany); FITC mouse
anti-rat CD45 (1:20 BD Pharmingen) and CD34 (1:20 from
DakoCytomation, Barcelona, SP). FACS data were generated
by DIVA software (BD Bioscience). Negative control staining
was performed using FITC-conjugated mouse IgG1k isotype,
PE-conjugated mouse IgG1k isotype and PE-Cy5.5-conjugated
mouse IgG1k isotype (all from BD Pharmingen). Cells were fixed
in 4% paraformaldehyde in PBS. After fixation, the cells were
washed twicewith PBS, permeabilized with PBS containing 0.1%
Triton X-100 (Sigma-Aldrich) for 10 min, then pre-blocked with
3% bovine serumalbumin (BSA) and incubatedwith the different
antibodies tested for 30 min at room temperature. The stained
cells were then washed twice with PBS and 1 × 105 cells were
analyzed.Cloning procedure
Full length human PG, LMNA and green fluorescent protein
(GFP) cDNAswere amplified by polymerase chain reaction (PCR)
from pBABE-puroGFP-progerin and pBABE-puroGFP-lamin
A plasmids (Addgene, donated by Tom Misteli), using the
oligonucleotides EcoRI-LMNA-forward: CCGGAATTCATGGAGA
CCCCGTCCCAGCGG, BamHI-LMNA-reverse: CGCGGATCCTTACA
TGATGCTGCAGTTCTG, EcoRI-GFP-forward: CCGGAATTCATGG
TGAGCAAGGGCGAG, BamHI-GFP-reverse: CGCGGATCCTTACTT
GTACACCTCGTC. GFP, LMNA and PG were cloned into pLVX-
puro (Clontech Laboratories Inc., Mountain View, CA) in
1139Lamin A deregulation in human MSCs and osteoarthritisbetween the EcoRI/BamHI sites following standard cloning
procedures.
Lentiviral production
The Lenti-X™ Lentiviral Expression System (Clontech Labora-
tories Inc.) was used following the manufacturer's protocol.
One day before transfection 4 × 106 293T producer cells were
placed on 100 mm plates in penicillin/streptomycin-free DMEM
supplemented with 5% FBS. The following day, three different
calcium-phosphate based transfections were performed using
LVX-GFP-puro, LVX-Progerin-puro and LVX-lamin A-puro. The
cells were incubated overnight with the transfection mixture,
then washed with PBS and incubated with 8 mL of fresh
complete growth medium.
Viral supernatants were collected at 48 h, 60 h and 72 h
following transfection, centrifuged, filtered to remove cell
debris and stored at 4 °C until transduction.
Transduction of human UC MSCs
Target cells were plated in 100 mm plates at 6 × 106 cells
per plate. After one day, the cells were 70% confluent. The
cells were incubated sequentially with the 48 hour, 60 hour,
and 72 hour viral supernatants for 12 h. Following the last
transduction, the cells were washed and incubated with fresh
growth medium to allow puromycin-resistance expression.
Two days later, puromycin selection was performed by
incubating the cells in growth media supplemented with
1 μg/mL puromycin (Clontech Laboratories Inc.) for five
days. After selection, transduced cells were washed and
allowed to recover in complete media for two days.
Proliferation assay
Different numbers of cells (0, 1000, 2000, 4000, 8000 and
16,000), plated in triplicate in 96-well plates and allowed to
adhere for 8 h, were used to calculate the proliferation curve.
The number of cells was then calculated using CellTiter 96®
AQueous Non-Radioactive Cell Proliferation Assay (Promega,
Madison, WI, USA) following manufacturer's instructions. For
the assay, 4000 cells were plated for each cell line in triplicate
in 96-well plates, and the total number of cells was calculated
at different time points (0, 2, 4 and 6 days).
Chondrogenic differentiation
MSCs transduced with GFP, LMNA or PG were seeded into
96-well plates (Sarstedt, Inc., Barcelona, SP) at 2 × 104 cells
per well in DMEM with 10% FBS, 1% penicillin, 1% streptomycin,
1.5 × 10−4 M monothioglycerol (MTG), 5 mg/mL ascorbic acid
(AA), and 6 μg/mL transferrin (TRANS) (all from Sigma-Aldrich)
to facilitate spontaneous spheroid formation. The medium
was then changed after two days to chondrogenic medium
composed of DMEMwith 15% knockout serum (Gibco, Invitrogen,
Barcelona, SP), 5 mg/mL AA, 6 μg/mL TRANS, 10 μM dexa-
methasone (DEX), 1 × 10−7 M retinoic acid and 1 ng/mL recom-
binant human transforming growth factor-β3 (rhTGF-β3)
(ProSpec-Tany TechnoGene, Deltaclon, Madrid, SP). This
medium was changed every three days. After 21 days in thechondrogenic medium, the spheroids formed were collected,
frozen and stored at −80 °C for later analyses. For the
N-acetyl-cysteine (NAC) pulses, spheroids were incubated
with DMEM, 10% knockout serum (Gibco, Invitrogen), 1%
penicillin and 1% streptomycin (Sigma-Aldrich) with 20 μg
NAC for 1 h daily for three days prior to regular change of
the differentiation media. Control spheroids were incubated
under the same conditions in DMEM with 10% knockout serum,
1% penicillin, and 1% streptomycin without NAC.
Adipogenic and osteogenic differentiation
MSCs transfected with LMNA, PG or GFP were seeded
into 96-well plates (Sarstedt Inc.) at 2 × 104 cells per well
in adipogenic or osteogenic commercial medium (Cambrex,
Lonza, A Coruña, SP), following themanufacturer's instructions,
to assess the mesoderm differentiation potential. Adipogenic
cultures were stained with Oil Red O after 21 days of culture.
For staining, the culture plates were fixed in 10 mM
sodium periodate, 2% paraformaldehyde, 75 mM L-lysine
dihydrochloride, and 37.5 mM dibasic sodium phosphate
(Sigma-Aldrich) at pH 7.4 for 15 min at room tempera-
ture, then air dried and treated with a filtered solution
of 0.3% Oil Red O to stain lipid droplets. After 21 days in
culture, the osteogenic cultures were stained with alizarin
red S to assess calcium deposits. Following fixation, the cells
were covered with alizarin red S 2% aqueous solution at pH 4.2
(Sigma-Aldrich) for 3 min, thenwashed thoroughlywith distilled
water.
RNA extraction and cDNA synthesis
Total RNA was extracted from cultured cells using the Trizol
L.S. reagent method (Invitrogen). Reverse transcription (RT)
used the SuperScript II system (Invitrogen). Total RNA (2 μg)
was reverse transcribed in a 20 μL reaction volume containing
SuperScript II (200 units), random primers (25 μM), and dNTP
(0.5 mM each) at 42 °C for 50 min.
Real-time reverse transcriptase PCR
(RT-PCR) analysis
The reported sequences of genes for human SOX2 (forward:
gtacccgcacttgcacaac; reverse: tcgctctcgttcagaagtctc), Nanog
(forward: atgcctcacacggagactgt; reverse: aagtgggttgtttgccttt
g), Oct3/4 (forward: ctcctggagggccaggaatc; reverse: atata
cacaggccgatgtgg), SOX9 (forward: ctccgggacatgatcagc;
reverse: ggtagtgctgggacatgtgaa), lipoprotein lipase (LPL)
(forward: agaacatcccattcactctgc; reverse: ccatttgagcttcaa
catgagt), fatty acid binding protein (FABP) (forward: ggat
gataaactggtggtgga; reverse: cacagaatgttgtagagttcaatc),
adiponectin (ADIPOQ) (forward: ggtgagaaaggagatccaggt;
reverse: tgctgagcggtatacataggc), alkaline phosphatase (ALP)
(forward: gacggacccgtcactctc; reverse: gtgcccgtggtcaattct),
osteocalcin (OC) (forward: ggcgctacctgtatcaatgg; reverse: tca
gccaactcgtcacagtc), Runx2 (forward: gtgcctaggcgcatttca;
reverse: tgactggcggcgtgcaag), aggrecan (AGG) (forward: g
cctacgaagcaggctatga; reverse: gcacgccataggtcctga) and
RPLP (forward: tctacaaccctgaagtgcttgat; reverse: caatctg
cagacagacactgg) as housekeeping were used for primer
design. SOX9 was used to check the expression of genes
1140 J. Mateos et al.involved in the early chondrogenic stage. Nanog and Sox2
were used to check the expression of genes involved in non-
differentiation stages. Genes for human LPL, FABP and
ADIPOQ, identified with early and late adipogenic differenti-
ation, and ALP, OC and Runx2 with early and late osteogenic
differentiation, were utilized to determine the success of
differentiation. The amplification program consisted of an
initial denaturation at 92 °C for 2 min followed by 40 cycles
from 92 °C for 15 s, annealing at 61 °C for 30 s, and an
extension at 72 °C for 15 s. Each PCR analysis was done in
duplicate, with each set of assays repeated three times. To
minimize effects of unequal quantities of starting RNA and to
eliminate potential sources of inconsistency, relative expres-
sion levels of each gene were normalized to RPLP using the
2-ΔΔCt method (Livak and Schmittgen, 2001). Control exper-
iments contained no reverse transcriptase.
Histological, immunofluorescence and
immunohistochemical analysis
Spheroids engineered fromMSCs following their differentiation
into chondrocyte-like cells were frozen in OCT embedding
matrix (BDH Chemicals, Poole, UK). Full-depth sections (4 μm)
were cut with a cryostat and fixed in 4% (w/v) paraformal-
dehyde (Sigma-Aldrich) in PBS at pH 7.6. Some sections
were stained with safranin O (Sigma-Aldrich) to evaluate
the distribution of proteoglycans, others were immunostained
with monoclonal antibodies against collagen type 1 (COL1;
1:1000), collagen type 2 (COL2; 1:50) and collagen type 10
(COLX ;1:2000), matrix metalloproteinase-13 (MMP-13; 1:200)
and aggrecan (AGG ; 1:50) (Southern Biotechnologies,
Birmingham, AL USA) and treated as described by Arufe et al.
(2009). Biotinylated secondary antibodies were detected
using a peroxidase-labeled biotin–streptavidin complex
(Vectastain Elite kit; Vector Laboratories, Peterborough,
UK) with diaminobenzidine substrate (Vector Laboratories)
(1:1000). Normal mouse serum was used for the negative
control, and the sections were not counterstained.
Control-MSCs and transducedMSCswere grown in 8-chamber
slides at a density of 2 × 104 cells per chamber. When they
reached 80% confluency, cells were fixed with paraformal-
dehyde 5% in phosphate buffered saline and processed as
previously described (Arufe et al., 2009) in order to study the
nuclear morphology by immunofluorescence using mouse lamin
A + C (Acris Antibodies) (1:100) as primary antibody and PE-anti
rabbit (BD Science) (1:1000) as secondary antibody.
Densitometry analysis
AnalySIS Image Processing was used to quantify the expression
of antibodies obtained by immunohistochemical analyses of
sections of spheroids. Three 200 mm2 fields were quantified for
each antibody; immunohistochemistry values were expressed
in arbitrary units assigned by computer program. The values
were expressed as percentage of positive cells for each of
the markers studied.
Immunoblot procedures
Immunoblot analysis was performed on 20 μg of total protein
extracted from cells in culture, as previously described(Matsushime et al., 1994). The antibodies used were mouse
lamin A + C (Acris Antibodies), rabbit β-catenin (Santa
Cruz Biotech., Santa Cruz, CA), rabbit notch-2 (Santa Cruz
Biotech.), rabbit glycerol-3-phosphate dehydrogenase (GPDH)
(Amersham),mouseMnSODM (Santa Cruz Biotech.), and rabbit
AKT (Cell Signaling, Danvers MA). Secondary anti-mouse and
anti-rabbit antibodies (Amersham) were used to visualize
proteins by the ECL™ Western Blotting Analysis System (GE
Healthcare, Amersham Biotechnology, UK). N = 3. Ideal con-
centrations for each antibody were determined empirically.
Working concentrations were 1:1000 of the stock solutions.
ROS measurement
The percentage of positive cells after treatment with DCFH-
DA-2′7′-dichlorofluorescein diacetate (Fluka) was calculated in
triplicate as previously described (Cillero-Pastor et al., 2008).
Briefly, 500,000 cells plated in 6-well plates were allowed
to grow to 80% confluence, then incubated sequentially with
or without NAC for 1 h, washed, and incubated with 10 μM
DCFH-DA for 30 min. The cells were then recovered in a tube
and analyzed using flow cytometry in a FACSAria instru-
ment (Benton Dickinson). The percentage of positive cells
was measured for each condition by fluorescent emission at
488 nm; basal levels calculated from the control without
fluorophore were subtracted for each measurement.
Oriented cell migration assay
Cells were detached from regular Petri dishes after reaching
a confluence of 80% and 50,000 cells of each cell line were
seeded in triplicate on the upper compartment of a modified
Boyden's chamber (Corning, Cultek SLU, Madrid, SP) in 200 μL
of serum-free medium. The chambers were then introduced in
24-well plates with either serum-free medium or serum-free
medium supplemented with 10 ng/mL of stromal cell-derived
factor-1 (SDF-1) or 50 pg/mL of interleukin-8 (IL-8) as chemo-
tactic agents. After 24 hour incubation in normoxic conditions,
cell migration through the filter were evaluated by trypan-
blue cell staining and cell counting in 18 randomly selected
microscopy fields.
Statistics
All experiments were done in triplicate and representative
results are shown. Statistical analyses used were Student's t
test and analysis of variance (ANOVA) using SPSS 16.0 (source).
P b 0.05 was considered statistically significant — P b 0.1 for
the chondrogenic differentiation with NAC.
Results
LMNA and PG accumulation in LMNA-MSCs
and PG-MSCs
The expression of lamin isoforms in GFP-MSCs was similar to
their expression in non-transduced MSCs. PG over-expression
in PG-MSCs produced alterations in the nuclear membrane
(blebs and LMNA accumulation), typical from PG-expressing
cell lines (Fig. 1A). The efficiency of gene delivery and protein
1141Lamin A deregulation in human MSCs and osteoarthritisexpression was determined using immunoblot analysis of
the transduced cells with anti-lamin A + C antibody. Ag1972
HGPS cell line was included as a positive control. LMNA-MSCs
showed accumulation of wild type (wt) LMNA and its precursor
pre-lamin A (PLMNA) (Fig. 1B). PG-MSCs expressed the lower
molecular weight isoform progerin (PG). Mild nuclear defects
are only eventually detected in LMNA-MSCs. Furthermore,
LMNA and PG over-expressing MSCs show a decrease in their
proliferation rate (Fig. 1C).
GFP-MSCs differentiation potential comparing to
that of non-transduced MSCs
To use the GFP-transduced cells as controls for the
differentiation study, we first characterized this cell line.
The expression of stem cell genes, including Nanog, Oct4 and
Sox9, was not significantly different when GFP-MSCs were
compared to non-transduced MSCs as determined by real-time
RT-PCR (Supplementary Fig. 1A). Primary chondrocytes usedFigure 1 Characterization of mesenchymal stem cells (MSCs)
fluorescent protein (GFP). Representative image of the immunofl
anti LMNA antibody (A). Representative image of Western-blot
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as
cell lines (C). PLMNA = pre-LMNA; MSC = mesenchymal stem cellsas a control did present a significantly (P b 0.05) higher
expression of Sox9, an early chondrogenesis gene, compared to
GFP-MSCs and non-transduced MSCs (Supplementary Fig. 1A).
The directed differentiation of GFP-MSCs and non-transduced
MSCs toward adipogenesis (Supplementary Figs. 1D–F),
osteogenesis (Supplementary Figs. 1G–I) and chondrogenesis
(Supplementary Figs. 1J–L), did not produce any significant
differences between the two cell types when examined by
immunohistochemistry and RT-PCR analyses.Differential potential of PG-MSCs and LMNA-MSCs vs
GFP-MSCs
After 21 days in osteogenic medium, almost 100% of the
GFP- and LMNA-transduced cells were positive for alizarin
red stain, compared with 40% of the PG-MSCs (Figs. 2A–B,
Supplementary Fig. 2). Genetic studies revealed that LMNA-
MSCs expressed the highest level of the OC gene, whiletransduced with progerin (PG), lamin A (LMNA) or green
uorescence analysis of the nuclear distribution of LMNA using
analysis using LMN A + C antibody from three experiments.
the housekeeping gene (B). Proliferation rate of the different
not transduced; Ag1972 = HGPS cell line.
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expression (Fig. 2B).
Almost 45% of the seeded GFP-MSCs and LMNA-MSCs were
positive for Oil Red O stain, showing adipogenesis, compared
with 25% of the PG-MSCs (Figs. 2C–D, Supplementary Fig. 2).
The expression of the LPL and FABP genes was significantly
(P b 0.05) higher in LMNA-MSCs than in the GFP-MSCs controls,
by as much as 100-fold. In contrast, the expression of these
genes was lower in PG-MSCs than in GFP-MSCs (Fig. 2D).
PG-MSCs present a chondrogenic characteristic ratio of
COL2 to COL1 significantly much lower than LMNA-MSCs and
GFP-MSCs, as revealed by immunohistochemistry (Fig. 3A) and
RT-PCR (Fig. 3B). The histomorphologic study of chondrogen-
esis demonstrated that PG-MSCs had decreased staining for
COL2 and safranin O (proteoglycans) compared to LMNA-MSCs
and GFP-MSCs (Fig. 3C and Supplementary Fig. 2). These results
were corroborated by real-time RT-PCR analysis of COL2 and
AGG gene expression (Fig. 3D). Hypertrophy studies during
chondrogenesis used immunohistochemistry to demonstrate* P<0.05 vs G
A) B)
C) D)
Figure 2 Osteogenic and adipogenic potential of mesenchymal ste
green fluorescent protein (GFP). Cultures were stained with alizarin r
deposit staining (A). Real-time reverse transcriptase polymerase ch
genes ALP and OC for the three cell lines (B). Oil Red O staining
(C). Real-time reverse transcriptase polymerase chain reaction (RT
FABP for the three cell lines (D). *P b 0.05 is considered significantthe role of LMNA and PG in the process of MSC differentiation.
Immunohistochemical analysis of the hypertrophymarker COLX
demonstrates that this protein was significantly increased
in both PG and LMNA-MSCs (Fig. 3E and Supplementary Fig. 2);
this finding was validated by real-time RT-PCR (Fig. 3F).
The gene expression of MMP-13, another classical hypertrophy
marker, was significantly higher in LMNA and PG-MSCs (Fig. 3F).
In this case, the immunohistochemical analysis showed a
significant (P b 0.05) increase of MMP-13 only in PG-MSCs when
compared to control GFP-MSCs (Fig. 3E and Supplementary
Fig. 2).Role of reactive oxygen species
Western-blot analysis showed that MnSODM expression is
diminished in both PG-MSCs and LMNA-MSCs compared to the
control GFP-MSCs (Fig. 4A). The spontaneous production of ROS
was significantly (P b 0.05) higher in PG-MSCs and LMNA-MSCsFP-MSCs
m cells (MSCs) transduced with progerin (PG), lamin A (LMNA) or
ed S to assess calcium deposits; densitometry analysis of calcium
ain reaction (RT-PCR) analysis of the osteogenic differentiation
of lipid vesicles; densitometry analysis of the Oil-Red staining
-PCR) analysis of the adipogenic differentiation genes LPL and
using Student's t test versus GFP-MSCs.
1143Lamin A deregulation in human MSCs and osteoarthritisthan in the control GFP-MSCs (Fig. 4B). Treatment of the cells
for 1 h with NAC reduced the accumulation of ROS from the
baseline levels (Fig. 4B).
Oriented migration capacity of PG-MSCs and LMNA-MSCs
in a modified Boyden's chamber assay under the effect of
two inflammation-related chemotactic agents, SDF-1 and
IL-8, is significantly increased when compared to the control
GFP-MSC cell line (Fig. 4C).* P<0.05 vs G
A) B)
C) D)
E) F)
Figure 3 Chondrogenic potential and markers of hypertrophy d
(MSCs) transduced with progerin (PG), lamin A (LMNA) or green fluo
collagen type 2 (COL2) and collagen type 1 (COL1). COL2/COL1 ratio
reaction (RT-PCR) analysis of the COL2/COL1 ratio (B). Densitome
(C). Real-time reverse transcriptase polymerase chain reaction (RT-P
AGG (D) for the three cell lines. Densitometry analysis of the immun
type X (COLX) (E). Real-time reverse transcriptase polymerase chai
MMP13 (F). *P b 0.05 was considered significant using Student's t anTo examine the role of ROS in chondrogenic differentia-
tion of the three MSC lines, we analyzed the effect of NAC
on the process. Real-time RT-PCR revealed a statistically
significant (P b 0.1) increase in the COL2/COL1 ratio of gene
expression levels in cells treated with NAC in the GFP-MSC
and LMNA-MSC cell lines (Fig. 5A). The PG-MSC line was
not affected by treatment with NAC, although COL2 gene
expression levels were significantly (P b 0.1) higher inFP-MSCs
uring chondrogenic differentiation of mesenchymal stem cells
rescent protein (GFP). Densitometry of the immunostaining for
is shown (A). Real-time reverse transcriptase polymerase chain
try analysis of COL2 and safranin O staining of proteoglycans
CR) analysis of the chondrogenic differentiation genes COL2 and
ostaining for matrix metalloproteinase-13 (MMP13) and collagen
n reaction (RT-PCR) analysis of hypertrophy markers COLX and
alysis versus GFP-MSCs.
1144 J. Mateos et al.NAC-treated compared to NAC-untreated PG-MSCs (data
not shown).
In NAC-treated cultures, compared to untreated controls,
AGG gene expression increased (Fig. 5B) and MMP-13 gene
expression decreased (Fig. 5C) in LMNA-MSC and PG-MSC cell
lines. In GFP-MSCs there were no significant changes in AGG
and MMP-13 gene expression. As well as the same results
were found by immunohistochemistry analysis (Fig. 5D).Figure 4 Levels of manganese superoxide dismutase (MnSODM), re
(MSCs) transduced with progerin (PG), lamin A (LMNA) or green fluores
Western blot analysis of the lamin isoforms and MnSODM in the th
(GAPDH) was used as the housekeeping gene. Flow cytometry of GF
N-acetyl-cysteine (NAC) or treatment with hydrogen peroxide (H2O2)
H2O2 = 20 μg; DCFH = 10 μM 2′7′-dichlorofluorescein diacetate contr
their oriented attraction capacity to SDF-1 and IL-8 (C). *P b 0.05 wasDiscussion
We have demonstrated that deregulation of LMNA in our
previously characterized chondrogenic model compromised
chondrogenic differentiation through, partially, redox imbal-
ance. Lamin A is a key factor regulating both normal and
accelerated aging as well as stem cell differentiation. Aging is
defined as the accumulation of diverse deleterious changesactive oxygen species ROS production of mesenchymal stem cells
cent protein (GFP) and the effect on oriented migration capacity.
ree cell lines (A). Glyceraldehyde 3-phosphate dehydrogenase
P-MSCs, LMNA-MSCs and PG-MSCs after one hour incubation with
(B). Iso = no treatment; NAC20 = 20 μg NAC; NAC40 = 40 μg NAC;
ol. Modified Boyden's chamber assay of the three cell lines to test
considered significant using Student's t test versus GFP-MSCs.
1145Lamin A deregulation in human MSCs and osteoarthritisoccurring in cells and tissues with advancing age that are
responsible for the increased risk of disease and death (Harman,
2003). Aging is now considered to be a very complex, multi-
factorial process. Several aging theories have been proposed
(Tosato et al., 2007), but no single theory explains all the major
age-related physiological changes.
Premature aging syndromes are used as models to partially
understand molecular causes of normal aging changes. Among
those syndromes, Hutchinson–Gilford Progeria Syndrome
(HGPS) is one of the most studied. Recent studies have
proposed that stem cell dysfunction enhances both normal
and premature aging symptoms (Scaffidi and Misteli,
2008; Zhang et al., 2011). To examine that premise in our* P<0.1 vs wi
A)
B)
C)
Figure 5 Effect of reactive oxygen species (ROS) on chondrogenic d
green fluorescent protein (GFP), lamin A (LMNA) or progerin (PG). G
N-acetyl-cysteine (NAC). Read procedure in Material and methods. Re
analysis for markers of chondrogenic differentiation and hypertrophy
was considered significant using Student's t test versus controls withou
from immunohistochemistry analysis with different antibodies againstmodel of mesoderm line differentiation, and, specifically,
chondrogenic differentiation through spheroid formation
employing human UC MSCs, we used a lentiviral system
to efficiently deliver genes of wt LMNA, PG and GFP, as a
control. Gene expression levels were determined by immuno-
blot; LMNA-MSCs accumulated wt LMNA and PG-MSCs accumu-
lated PG. The low level of PG detected may reflect the low
passage number of the cell line, but is similar to the level found
in an HGPS-derived fibroblast cell line, AG01972. Besides,
nuclear defects and a decrease in the proliferation rate, both
typical from PG-expressing, pre-senescent cells, are detected
in PG-transduced MSCs. Mild nuclear defects and a decrease in
proliferation rate are also detected in LMNA-transduced MSCs,thout-NAC
D)
ifferentiation of mesenchymal stem cells (MSCs) transduced with
FP-MSCs, LMNA-MSCs and PG-MSCs were incubated with 20 μg of
al-time reverse transcriptase polymerase chain reaction (RT-PCR)
COL2/COL1 ratio (A), AGG (B) and MMP13 (C) are shown. *P b 0.1
t NAC treatment. (D) Representative images of the tissue section
COL2, COL1, AGG and MMP-13. Magnification: 20×.
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could alter the nuclear lamina similarly to PG accumulation,
which agrees with previously published data (Young et al.,
2006). By contrast, GFP-MSCs present similar proliferation rate
than non-transduced MSCs. Therefore, we decided to use the
GFP-MSCs as control for the differentiation experiments.
We previously characterized MSCs from human umbilical
cord stroma by flow cytometry (Supplementary Fig. 3)
which showed a similar percentage of positive cells for surface
markers CD105, CD90 and CD73 and negative for CD45 and 34 as
found in former works by Arufe et al. (2011). We demonstrated
that GFP-MSCs retain a differentiation potential similar to that
of non-transduced MSCs. We then used the GFP-MSCs as a
control for differentiation experiments for several reasons.
Unlike non-transduced MSCs, GFP-MSCs were transduced in
parallel with the other cell lines that underwent lentiviral
infection and puromycin selection. Also, GFP-MSCs over-express
an exogenous protein. Extensive studies documented in the
literature have verified that expression of GFP is innocuous
for the cells. Finally, a recently published study demonstrated
that lentiviral delivery of GFP into human UC MSCs did not
affect their pluripotency (Qian et al., 2010). Alterations
in the mesoderm differentiation potential were seen in the
transduced cell lines, where osteogenesis, adipogenesis,
and especially chondrogenesis were compromised in PG-MSCs
compared to controls. In ourmodel, we found calcium deposits
secreted by PG-MSCs to be decreased after 21 days in
osteogenic medium compared to GFP-MSCs. One possible
explanation for this might be the low level of expression of
the ALP gene in these cells. In contrast, the significantly
higher OC gene expression in LMNA-MSCs may indicate that
osteogenesis is not altered in these cells.
After 21 days in adipogenic medium, adipogenic capacity
was lessened in PG-MSCs, demonstrated by a significantly
lower expression of LPL and FABP genes than in control cells,
as well as significantly lower (close to 50%) Oil Red staining.
In contrast, LMNA-transduced cells show a significant increase
in the expression of those adipogenicmarkers. Our results differ
from those found previously by Kha et al. (2004). From their
results, wewould have expected to find an improved osteogenic
potential in PG-MSCs because adipogenesis was reduced. One
possible explanation for this unexpected result may be that
all mechanisms of mesoderm differentiation in PG-MSCs were
deregulated as a consequence of the over-expression of PG in
our model.
Chondrogenic differentiation in our model is affected
by deregulation of LMNA, especially in PG-MSCs, as revealed
by a lowered COL2/COL1 ratio and lower expression of COL2
and AGG as shown by real-time RT-PCR. While our findings do
not completely agree with the results of the study by Scaffidi
and Misteli (2008), any discrepancies may be explained by the
different gene delivery methods, different origins of the MSCs,
and the different differentiation models employed.
The hypertrophy markers, MMP-13 and COLX, were
detected significantly elevated in PG-MSCs by immunohisto-
chemistry, compared to control, after 21 days in chondrogenic
medium. Also, LMNA-MSCs presented an increase in COLX,
but not in MMP-13. Real-time analysis showed that these two
hypertrophy markers were significantly elevated in both PG
and LMNA-MSCs. These results were similar to those found in
OA chondrocytes (Blanco et al., 2011). Mitochondrial dysfunc-
tion and oxidative stress are known to be responsible forderegulation of chondrogenesis (Ruiz-Romero et al., 2009;
Scott et al., 2010). We have previously reported that MnSODM
is down-regulated in OA and that mitochondrial dysfunction and
oxidative stress are responsible for deregulation of chondro-
genesis (Blanco et al., 2011). Hence, we proposed to ascertain
whether the diminished chondrogenic potential of LMNA-MSCs
and PG-MSCs is linked to defects in MnSODM and oxidative stress
imbalance. We investigated MnSODM levels at day 0. Western
blot analysis demonstrated a decrease in total MnSODM in both
cell lines, which was accompanied by a stable accumulation
of ROS. This accumulation is partially, and dose-dependently,
reversed by incubation of the cells with the antioxidant com-
pound NAC, which acts as a ROS scavenger. Previously, a rapid
and transitory increase in ROS generation in human MSCs from
bone marrow has been proposed as the initial factor to sustain
the migratory capacity of these cells (Busletta et al., 2011)
suggesting a biphasic scenario for in vivo reparation of injured
tissues. We decided to study if the migratory capacity in our in
vitro model is altered in PG and LMNA-overexpressing umbilical
cord MSCs. Modified Boyden's chamber assay shows that
these cells present an increased oriented migration capacity
activated by two inflammatory chemokines, SDF-1 and IL-8,
when compared to control GFP-MSCs. It is not unreasonable
to think that the stable increase in ROS generation that we
detected in our MSC model when the expression of lamin A is
permanently altered, may interfere with the chain of events
that leads to a proper migration of this cells.
Gene expression levels of COL2 and COL1 were measured
by real-time RT-PCR after 21 days in chondrogenic medium
with and without NAC. The COL2/COL1 ratio indicates
that NAC treatment improves chondrogenic differentiation.
This ratio is significantly higher in GFP-MSCs and LMNA-MSCs,
comparing NAC-treated and -untreated cells, but not in PG-
MSCs, although the COL2 gene expression level was higher
in NAC-treated compared to NAC-untreated PG-MSCs (data
not shown). The hypertrophy phenotype is lessened by NAC
treatment in LMNA- and PG-transduced cells, as shown by
increased AGG and decreased MMP-13 gene expression levels.
These results indicate that LMNA-MSCs and PG-MSCs were more
sensitive to NAC treatment because of an accumulation of ROS
that correlates with a decrease in MnSODM protein levels. Our
results are in agreement with those of Morita et al. indicating
that ROS levels regulate the inhibition of proliferation and
modulate the initiation of hypertrophic changes in chondrocytes
(Morita et al., 2007) and with recent work demonstrating the
importance of ROS levels during stem cell differentiation (Hao
et al., 2011) (Aly et al., 2011).Conclusion
Overall, our results show that chondrogenic differentiation
of UC-MSCs is compromised by lamin A deregulation. We also
demonstrated that this deregulation alters the oxidative
stress balance in MSCs, modifies their migratory properties
and induces defects in their capacity to differentiate into
chondrocytes in our in vitro model. Further experiments are
necessary to determine the in vivo significance of these
alterations and to explore putative key targets for stem
cell therapies in OA and other aging syndromes.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2013.07.004.
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